(Unterschied) ← Nächstältere Version | Aktuelle Version (Unterschied) | Nächstjüngere Version → (Unterschied)
32545518 2020. Nrf2 Activator PB125((R)) as a Potential Therapeutic Agent against COVID-19.
32606823 2020. Potential Role of Nrf2 Activators with Dual Antiviral and Anti-Inflammatory Properties in the Management of Viral Pneumonia.
32577056 2020. The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role?
| 32711925 2020. Can Activation of NRF2 Be a Strategy against COVID-19?
|
32722164 2020. Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity.
32996197 2020. Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway.
33009401 2020. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
33291560 2020. Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications.
| 33292691 2020. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.
|
